Framework agreement for the purchase of Tibsovo® (ivosidenib)

This framework agreement aims to ensure the supply of the pharmaceutical product Tibsovo® (ivosidenib) to the hospital pharmacies of Amgros' stakeholders. The Capital Region's hospital pharmacy will also procure the medication for resale to Greenland and the Faroe Islands. Tibsovo® (ivosidenib) is a specific drug, likely used for therapeutic purposes, and the framework agreement will establish the terms and conditions under which this medication can be procured over a defined period. The agreement is intended to streamline the procurement process, ensure consistent availability, and potentially achieve favorable pricing through a consolidated purchasing approach. Amgros, acting as a central purchasing organization or facilitator, seeks to provide its stakeholders with reliable access to this critical medication. The framework agreement will likely detail specifications, quantities, delivery schedules, pricing mechanisms, and quality assurance requirements. This procurement is crucial for maintaining the supply chain of essential medicines for healthcare providers within the specified regions.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.